Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · May 30, 2023

Minimal Residual Disease Assessment and Impact of Methotrexate Dose on Survival in Childhood ALL

Journal of Clinical Oncology


Additional Info

Journal of Clinical Oncology
Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Acute Lymphoblastic Leukemia Intercontinental-Berlin-Frankfurt-Münster 2009 Trial
J. Clin. Oncol 2023 May 04;[EPub Ahead of Print], M Campbell, C Kiss, M Zimmermann, C Riccheri, J Kowalczyk, MS Felice, M Kuzmanovic, G Kovacs, H Kosmidis, A Gonzalez, E Bilic, L Castillo, A Kolenova, J Jazbec, A Popa, D Konstantinov, J Kappelmayer, T Szczepanski, M Dworzak, B Buldini, G Gaipa, N Marinov, J Rossi, A Nagy, I Gaspar, J Stary, M Schrappe

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading